Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer

Cancer Letters

Volumn 321, Issue 1, 2012, Pages 89-99

  Stübke, Katrin ^a   Wicklein, Daniel ^a   Herich, Lena ^a   Schumacher, Udo ^a   Nehmann, Nina ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Breast cancer; Pfp rag2 mouse; Selectin; Spontaneous metastasis xenograft model

Indexed keywords

CA 19-9 ANTIGEN; CD15 ANTIGEN; CD24 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITHELIAL CELL ADHESION MOLECULE; HELIX POMATIA AGGLUTININ; HERMES ANTIGEN; LECTIN; MUCIN 1; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BONE MARROW METASTASIS; BREAST CANCER; CANCER CELL; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; EPCAM GENE; FEMALE; GENE; GENOTYPE; HUMAN; HUMAN CELL; LUNG ALVEOLUS WALL; LUNG METASTASIS; METASTASIS; MICROMETASTASIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; WILD TYPE;

ANIMALS; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; E-SELECTIN; HUMANS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; P-SELECTIN; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84860349839     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.019     Document Type: Article

References (56)

1. Fidler I.J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 1978, 38:2651-2660.
2. Carr I., Orr F.W. Invasion and metastasis. Can. Med. Assoc. J. 1983, 128:1164-1167.
3. Witsch E., Sela M., Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda) 2010, 25:85-101.
4. Weigelt B., Peterse J.L., van 't Veer L.J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 2005, 5:591-602.
5. Brooks S.A., Leathem A.J. Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet 1991, 338:71-74.
6. Thomas M., Noguchi M., Fonseca L., Kitagawa H., Kinoshita K., Miyazaki I. Prognostic significance of Helix pomatia lectin and c-erbB-2 oncoprotein in human breast cancer. Br. J. Cancer 1993, 68:621-626.
7. Schumacher U., Higgs D., Loizidou M., Pickering R., Leathem A., Taylor I. Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer 1994, 74:3104-3107.
8. Brooks S.A., Lymboura M., Schumacher U., Leathem A.J. Histochemistry to detect Helix pomatia lectin binding in breast cancer: methodology makes a difference. J. Histochem. Cytochem. 1996, 44:519-524.
9. Schumacher U., Adam E. Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice. Histochem. J. 1997, 29:677-684.
10. Schumacher U., Adam E., Flavell D.J., Boehm D., Brooks S.A., Leathem A.J. Glycosylation patterns of the human colon cancer cell line HT-29 detected by Helix pomatia agglutinin and other lectins in culture, in primary tumours and in metastases in SCID mice. Clin. Exp. Metastasis 1994, 12:398-404.
11. Valentiner U., Hall D.M., Brooks S.A., Schumacher U. HPA binding and metastasis formation of human breast cancer cell lines transplanted into severe combined immunodeficient (scid) mice. Cancer Lett. 2005, 219:233-242.
12. Kannagi R., Izawa M., Koike T., Miyazaki K., Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2004, 95:377-384.
13. Laubli H., Borsig L. Heparins attenuate cancer metastasis: are selectins the link?. Cancer Invest. 2009, 27:474-481.
14. Laferriere J., Houle F., Huot J. Adhesion of HT-29 colon carcinoma cells to endothelial cells requires sequential events involving E-selectin and integrin beta4. Clin. Exp. Metastasis 2004, 21:257-264.
15. Kim Y.S., Gum J., Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj. J. 1996, 13:693-707.
16. Matsumoto S., Imaeda Y., Umemoto S., Kobayashi K., Suzuki H., Okamoto T. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br. J. Cancer 2002, 86:161-167.
17. Kohler S., Ullrich S., Richter U., Schumacher U. E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br. J. Cancer 2010, 102:602-609.
18. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
19. Walsh C.M., Matloubian M., Liu C.C., Ueda R., Kurahara C.G., Christensen J.L., Huang M.T., Young J.D., Ahmed R., Clark W.R. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 1994, 91:10854-10858.
20. Lowin B., Peitsch M.C., Tschopp J. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top Microbiol. Immunol. 1995, 198:1-24.
21. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 2002, 71:101-132.
22. Sodeur S., Ullrich S., Gustke H., Zangemeister-Wittke U., Schumacher U. Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice. Cancer Lett. 2009, 282:146-151.
23. Viale G., Rotmensz N., Maisonneuve P., Bottiglieri L., Montagna E., Luini A., Veronesi P., Intra M., Torrisi R., Cardillo A., Campagnoli E., Goldhirsch A., Colleoni M. Invasive ductal carcinoma of the breast with the " triple-negative" phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res. Treat. 2009, 116:317-328.
24. Dent R., Hanna W.M., Trudeau M., Rawlinson E., Sun P., Narod S.A. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res. Treat. 2009, 115:423-428.
25. Rakha E.A., El-Sayed M.E., Green A.R., Lee A.H., Robertson J.F., Ellis I.O. Prognostic markers in triple-negative breast cancer. Cancer 2007, 109:25-32.
26. Choesmel V., Anract P., Hoifodt H., Thiery J.P., Blin N. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases. Cancer 2004, 101:693-703.
27. Frenette P.S., Mayadas T.N., Rayburn H., Hynes R.O., Wagner D.D. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996, 84:563-574.
28. Kim Y.J., Borsig L., Varki N.M., Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 1998, 95:9325-9330.
29. Mitchell B.S., Horny H.P., Schumacher U. Immunophenotyping of human HT29 colon cancer cell primary tumours and their metastases in severe combined immunodeficient mice. Histochem. J. 1997, 29:393-399.
30. Thies A., Peldschus K., Ittrich H., Adam G., Altevogt P., Wagener C., Schumacher U. Magnetic resonance imaging of melanoma metastases in a clinical relevant human melanoma xenograft scid mouse model. Cancer Lett. 2009, 274:194-200.
31. Jojovic M., Schumacher U. Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett. 2000, 152:151-156.
32. Nehmann N., Wicklein D., Schumacher U., Muller R. Comparison of two techniques for the screening of human tumor cells in mouse blood: quantitative real-time polymerase chain reaction (qRT-PCR) versus laser scanning cytometry (LSC). Acta Histochem. 2010, 112:489-496.
33. Osta W.A., Chen Y., Mikhitarian K., Mitas M., Salem M., Hannun Y.A., Cole D.J., Gillanders W.E. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004, 64:5818-5824.
34. Freudlsperger C., Moll I., Schumacher U., Thies A. Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro. Anticancer Drugs 2006, 17:325-332.
35. Khatib A.M., Fallavollita L., Wancewicz E.V., Monia B.P., Brodt P. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 2002, 62:5393-5398.
36. Tremblay P.L., Huot J., Auger F.A. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res. 2008, 68:5167-5176.
37. Richter U., Schroder C., Wicklein D., Lange T., Geleff S., Dippel V., Schumacher U., Klutmann S. Adhesion of small cell lung cancer cells to E- and P-Selectin under physiological flow conditions: implications for metastasis formation. Histochem. Cell Biol. 2011, 135:499-512.
38. Subramaniam M., Saffaripour S., Watson S.R., Mayadas T.N., Hynes R.O., Wagner D.D. Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J. Exp. Med. 1995, 181:2277-2282.
39. Laubli H., Borsig L. Selectins as mediators of lung metastasis. Cancer Microenviron. 2010, 3:97-105.
40. Chaffer C.L., Brennan J.P., Slavin J.L., Blick T., Thompson E.W., Williams E.D. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006, 66:11271-11278.
41. Tsuji T., Ibaragi S., Shima K., Hu M.G., Katsurano M., Sasaki A., Hu G.F. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res. 2008, 68:10377-10386.
42. Gumireddy K., Li A., Gimotty P.A., Klein-Szanto A.J., Showe L.C., Katsaros D., Coukos G., Zhang L., Huang Q. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat. Cell Biol. 2009, 11:1297-1304.
43. Lugo T.G., Braun S., Cote R.J., Pantel K., Rusch V. Detection and measurement of occult disease for the prognosis of solid tumors. J. Clin. Oncol. 2003, 21:2609-2615.
44. Pantel K., Alix-Panabieres C., Riethdorf S. Cancer micrometastases. Nat. Rev. Clin. Oncol. 2009, 6:339-351.
45. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4:448-456.
46. Greiner D.L., Hesselton R.A., Shultz L.D. SCID mouse models of human stem cell engraftment. Stem. Cells 1998, 16:166-177.
47. Hanna N., Fidler I.J. Role of natural killer cells in the destruction of circulating tumor emboli. J. Natl. Cancer Inst. 1980, 65:801-809.
48. Cooney C.A., Jousheghany F., Yao-Borengasser A., Phanavanh B., Gomes T., Kieber-Emmons A.M., Siegel E.R., Suva L.J., Ferrone S., Kieber-Emmons T., Monzavi-Karbassi B. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 2011, 13:R58.
49. Shirure V.S., Henson K.A., Schnaar R.L., Nimrichter L., Burdick M.M. Gangliosides expressed on breast cancer cells are E-selectin ligands. Biochem. Biophys. Res. Commun. 2011, 406:423-429.
50. Schweitzer K.M., Drager A.M., van der Valk P., Thijsen S.F., Zevenbergen A., Theijsmeijer A.P., van der Schoot C.E., Langenhuijsen M.M. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am. J. Pathol. 1996, 148:165-175.
51. Rood P.M., Calafat J., von dem Borne A.E., Gerritsen W.R., van der Schoot C.E. Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. Eur. J. Clin. Invest. 2000, 30:618-629.
52. Rood P.M., Dercksen M.W., Cazemier H., Kerst J.M., Von dem Borne A.E., Gerritsen W.R., van der Schoot C.E. E-selectin and very late activation antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endothelium. Ann. Hematol. 2000, 79:477-484.
53. Klein C.A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 2009, 9:302-312.
54. Engel J., Eckel R., Kerr J., Schmidt M., Furstenberger G., Richter R., Sauer H., Senn H.J., Holzel D. The process of metastasisation for breast cancer. Eur. J. Cancer 2003, 39:1794-1806.
55. Engel J., Lebeau A., Sauer H., Holzel D. Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection. Breast 2006, 15:452-455.
56. Holzel D., Eckel R., Emeny R.T., Engel J. Distant metastases do not metastasize. Cancer Metastasis Rev. 2010, 29:737-750.